Global Metabolic Testing Market Expected To Reach $0.91 Billion By 2030 At 7.3% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Projected Increase In Market Value Of The Metabolic Testing Market During 2026–2030?
The metabolic testing market size has experienced significant growth in recent years. This market is set to expand from $0.64 billion in 2025 to $0.69 billion in 2026, at a compound annual growth rate (CAGR) of 7.5%. The expansion observed historically is linked to the rising prevalence of obesity, increasing use of indirect calorimetry, greater adoption of cpets in hospitals, broader diagnostic applications, and a growing awareness of metabolic disorders.
The metabolic testing market is projected to experience robust expansion over the coming years. By 2030, its valuation is anticipated to reach $0.91 billion, demonstrating a compound annual growth rate (CAGR) of 7.3%. This projected increase during the forecast period is driven by several factors, including the proliferation of personalized wellness initiatives, the rising importance of sports performance analytics, a growing need for remote health monitoring solutions, the wider availability of wearable metabolic sensors, and the increasing incorporation of AI-powered diagnostic instruments. Key developments anticipated in this period encompass the uptake of tailored metabolic health regimens, AI-driven evaluation and forecasting of metabolic rates, cloud-based data tracking for metabolic assessments, the automation of metabolic testing apparatus, and real-time IoT-based body analytics.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21219&type=smp
Which Strong Drivers Are Impacting The Metabolic Testing Market Growth?
The increasing occurrence of chronic diseases is projected to stimulate the metabolic testing market moving forward. Chronic conditions are long-term health issues that typically last for at least a year, requiring ongoing medical care or impacting daily living activities. The widespread presence of chronic diseases is attributed to factors such as unhealthy lifestyles, poor nutritional habits, and an aging demographic. Metabolic testing plays a vital role in managing chronic diseases by providing valuable insights into an individual’s metabolic health, enabling the early detection of conditions like diabetes, cardiovascular diseases, and metabolic syndrome. This ultimately aids in personalizing treatment plans and improving overall disease management. For instance, in September 2023, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported 41 million deaths globally were due to chronic diseases, representing 74% of all fatalities each year. This figure encompasses 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Therefore, the growing prevalence of chronic diseases will drive the metabolic testing market.
What Are The Different Segment Types In The Metabolic Testing Market Segment Breakdown?
The metabolic testing market covered in this report is segmented –
1) By Equipment Type: Body Composition Analyzers, Cardiopulmonary Exercise Testing (CPET) Systems, Electrocardiogram Systems (ECG) Systems, Metabolic Carts, Other Equipment Types
2) By Technology: VO2 Max Analysis, RMR Analysis, Body Composition Analysis
3) By Application: Critical Care, Lifestyle Diseases, Other Applications
4) By End User: Hospitals And Clinics, Sports Training Centers, Other End Users
Subsegments:
1) By Body Composition Analyzers: Dual-Energy X-ray Absorptiometry (DXA), Bioelectrical Impedance Analysis (BIA), Air Displacement Plethysmography (ADP)
2) By Cardiopulmonary Exercise Testing (CPET) Systems: Treadmill Or Cycle Ergometer-based CPET, Oxygen Consumption Measurement Systems, Gas Exchange Measurement Systems
3) By Electrocardiogram (ECG) Systems: Resting ECG Systems, Stress ECG Systems, Holter Monitors
4) By Metabolic Carts: Indirect Calorimetry Metabolic Carts, Open-Circuit Spirometry Metabolic Carts
5) By Other Equipment Types: Continuous Glucose Monitoring Systems, Lactate Testing Devices, Blood Pressure Monitoring Devices
Which Trends Are Contributing To Changes In The Metabolic Testing Market?
Leading companies in the metabolic testing market are directing their efforts toward developing innovative diagnostic equipment, such as metabolic analyzers, to enhance real-time metabolic assessment and boost research accuracy. A metabolic analyzer is a medical instrument utilized to determine an individual’s metabolic rate and evaluate various metabolic functions. It measures the body’s efficiency in using oxygen and converting food into energy, thereby offering insights into calorie expenditure, fuel utilization (carbohydrates vs. fats), and respiratory performance. For instance, in September 2024, PHC Corporation, a Japan-based provider of healthcare solutions, launched LiCellMo, a live cell metabolic analyzer specifically designed for real-time visualization of cellular metabolism in the context of cell and gene therapy research. The LiCellMo live cell metabolic analyzer features unique capabilities, including real-time, continuous, and non-invasive monitoring of glucose and lactate concentrations within cell cultures, which provides a comprehensive understanding of cellular metabolism without disrupting ongoing experiments. This allows researchers to observe metabolic alterations in cell cultures, presenting a more complete depiction of cell activity.
Who Are The Well-Known Companies In The Metabolic Testing Market?
Major companies operating in the metabolic testing market are Becton Dickinson and Company, Lumen Technologies Inc., Laboratory Corporation of America Holdings LabCorp, Quest Diagnostics Incorporated, Agilent Technologies Inc., Vyaire Medical Inc., Microlife Medical Home Solutions Inc., MGC Diagnostics Corporation, Geratherm Medical AG, Actofit Wearables, COSMED Srl, Levels Health Inc, Cortex Biophysik GmbH, KORR Medical Technologies Inc., iWorx Systems Inc., General Electric Company GE Healthcare, Hologic Inc, Koninklijke Philips NV, Parvo Medics Inc, InBody Co Ltd, Schiller AG, Noraxon USA Inc, Seca GmbH Co KG
Get The Full Metabolic Testing Market Report:
https://www.thebusinessresearchcompany.com/report/metabolic-testing-global-market-report
Which Region Is The Top Contributor To The Metabolic Testing Market By Share?
North America was the dominant region in the metabolic testing market in 2025. Asia-Pacific is expected to be the exponential growth region in the forecast period. The regions covered in the metabolic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Metabolic Testing Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/metabolic-testing-global-market-report
Browse Through More Reports Similar to the Global Metabolic Testing Market 2026, By The Business Research Company
Peptide Based Metabolic Disorders Therapeutics Market Report 2026
Insuman Market Report
https://www.thebusinessresearchcompany.com/report/insuman-global-market-report
Dumping Syndrome Market Report
https://www.thebusinessresearchcompany.com/report/dumping-syndrome-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
